Nathan Weinstein
Stock Analyst at Aegis Capital
(0.33)
# 4,024
Out of 4,711 analysts
63
Total ratings
14.52%
Success rate
-24.61%
Average return
Main Sectors:
Stocks Rated by Nathan Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $100 → $80 | $1.35 | +5,825.93% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $20 → $15 | $0.80 | +1,775.00% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.68 | +787.71% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $1.00 | +3,400.00% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $2.31 | +159.74% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $2.37 | +1,165.82% | 5 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $4.05 | +146.91% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $16.49 | +197.15% | 4 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $350 → $10 | $0.33 | +2,976.92% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $2,160 | $4.10 | +52,582.93% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.68 | +1,685.71% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $750 → $600 | $0.48 | +124,226.56% | 2 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $0.89 | +1,023.47% | 2 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $160 | $23.22 | +589.06% | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $27.13 | +106.41% | 2 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $1.19 | +2,168.91% | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $1.00 | +3,400.35% | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.10 | +471.43% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $12.39 | +505.33% | 1 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $11 | $0.28 | +3,844.07% | 3 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $2.50 | +7,100.00% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $9 | $0.58 | +1,451.46% | 3 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $4.41 | +217.46% | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $0.46 | +2,291.30% | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8.5 | $2.69 | +215.99% | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100 → $80
Current: $1.35
Upside: +5,825.93%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $20 → $15
Current: $0.80
Upside: +1,775.00%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.68
Upside: +787.71%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $1.00
Upside: +3,400.00%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $2.31
Upside: +159.74%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $2.37
Upside: +1,165.82%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $4.05
Upside: +146.91%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $16.49
Upside: +197.15%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $350 → $10
Current: $0.33
Upside: +2,976.92%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $4.10
Upside: +52,582.93%
Dec 7, 2021
Initiates: Buy
Price Target: $30
Current: $1.68
Upside: +1,685.71%
Nov 15, 2021
Maintains: Buy
Price Target: $750 → $600
Current: $0.48
Upside: +124,226.56%
Nov 1, 2021
Maintains: Buy
Price Target: $9 → $10
Current: $0.89
Upside: +1,023.47%
Sep 22, 2021
Maintains: Buy
Price Target: $180 → $160
Current: $23.22
Upside: +589.06%
Sep 9, 2021
Maintains: Buy
Price Target: $60 → $56
Current: $27.13
Upside: +106.41%
Aug 17, 2021
Maintains: Buy
Price Target: $26 → $27
Current: $1.19
Upside: +2,168.91%
Jun 7, 2021
Maintains: Buy
Price Target: $40 → $35
Current: $1.00
Upside: +3,400.35%
Mar 22, 2021
Initiates: Buy
Price Target: $12
Current: $2.10
Upside: +471.43%
Jan 26, 2021
Initiates: Buy
Price Target: $75
Current: $12.39
Upside: +505.33%
Oct 19, 2020
Maintains: Buy
Price Target: $13 → $11
Current: $0.28
Upside: +3,844.07%
Oct 8, 2020
Initiates: Buy
Price Target: $180
Current: $2.50
Upside: +7,100.00%
Aug 3, 2020
Maintains: Buy
Price Target: $13 → $9
Current: $0.58
Upside: +1,451.46%
Jul 13, 2020
Initiates: Buy
Price Target: $14
Current: $4.41
Upside: +217.46%
May 4, 2020
Maintains: Buy
Price Target: $9 → $11
Current: $0.46
Upside: +2,291.30%
Mar 23, 2020
Initiates: Buy
Price Target: $8.5
Current: $2.69
Upside: +215.99%